The White House has unveiled a new strategy to tackle the nation’s drug crisis, advocating several public health initiatives. Key measures include the use of naloxone, a medication that reverses overdoses, medication-assisted treatment, and test strips to identify fentanyl and other harmful adulterants in the drug supply.
However, the May 4 document contrasts sharply with recent drug policy actions by the Trump administration. It follows the administration’s recent decision to impose restrictions on federal funding for distributing test strips and cautions against medication-assisted treatment unless accompanied by support services like counseling.
This document, released annually by the White House Office of National Drug Control Policy, is the first since Sara Carter, a former Fox News correspondent, was confirmed by the Senate in January.
Reflecting Carter’s background in reporting on cartel smuggling and Republican politics, the document emphasizes stringent measures such as constructing a border wall with Mexico, deporting drug traffickers, and targeting suspected drug boats in the Caribbean—a move some experts claim is illegal.
Notably absent from the strategy is any mention of syringe exchange programs, which are considered vital for preventing infectious diseases linked to injection drug use and providing accessible pathways to medical care.
Consistent with its earlier crackdowns on supervised consumption sites and test strips, the strategy avoids the term “harm reduction,” a method aimed at minimizing harm and disease among drug users without requiring them to quit.
The administration has shifted resources “toward transitional housing and treatment-focused programs [and] removing the enabling environment that allowed open-air drug use to fester in our cities,” according to the strategy document.
So far, the Trump administration’s most notable drug policy actions have involved reducing the role of the Substance Use and Mental Health Administration, which has never had a full-time leader appointed by the White House.
Funding has been a volatile issue, with billions initially canceled and then approximately $2 billion temporarily reinstated through the agency.
The Great American Recovery Initiative, supported by health secretary Robert F. Kennedy Jr. and Kathryn Burgum, the spouse of Interior Secretary Doug Burgum, has yet to yield substantial funding or policy proposals.
“ASAM appreciates the National Drug Control Strategy’s laudable goal of increasing access to evidence-based treatment for people with substance use disorders,” Stephen Taylor, president of the American Society of Addiction Medicine, said in a statement at a strategy rollout event on Wednesday. “The strategy rightly reinforces addiction as a chronic disease for which evidence-based treatments exist, including medication and psychosocial treatments that save lives and support recovery.”
STAT’s coverage of chronic health issues is supported by a grant from Bloomberg Philanthropies. Our financial supporters are not involved in any decisions about our journalism.
